Kissei Pharmaceutical Co., Ltd. (TYO:4547)
4,650.00
+20.00 (0.43%)
Feb 13, 2026, 3:30 PM JST
Kissei Pharmaceutical Revenue
Kissei Pharmaceutical had revenue of 26.80B JPY in the quarter ending December 31, 2025, with 15.51% growth. This brings the company's revenue in the last twelve months to 95.29B, up 14.28% year-over-year. In the fiscal year ending March 31, 2025, Kissei Pharmaceutical had annual revenue of 88.33B with 16.87% growth.
Revenue (ttm)
95.29B
Revenue Growth
+14.28%
P/S Ratio
2.02
Revenue / Employee
53.60M
Employees
1,778
Market Cap
192.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 88.33B | 12.75B | 16.87% |
| Mar 31, 2024 | 75.58B | 8.09B | 11.98% |
| Mar 31, 2023 | 67.49B | 2.11B | 3.23% |
| Mar 31, 2022 | 65.38B | -3.66B | -5.31% |
| Mar 31, 2021 | 69.04B | 5.81B | 9.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Toho Holdings | 1.53T |
| Towa Pharmaceutical | 266.67B |
| Sawai Group Holdings | 200.00B |
| Tsumura & Co. | 189.50B |
| Nippon Shinyaku | 166.05B |
| Hisamitsu Pharmaceutical Co. | 159.27B |
| KYORIN Pharmaceutical | 133.26B |
| Mochida Pharmaceutical | 111.92B |
Kissei Pharmaceutical News
- 10 months ago - Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - Benzinga